Novo-Passit® (Novo-Passit®)

Composition Pharmacodynamics Indications Carefully Contraindications Dosing and Administration Side effects Form release / dosage
Read on
Active substanceHawthorn flowers extract + Valerian officinal rhizomes with roots extractHawthorn flowers extract + Valerian officinal rhizomes with roots extract
Similar drugsTo uncover
  • Bromenval
    drops inwards 
    OMSKA FARMFABRIKA, OGUP     Russia
  • Novo-Passit®
    pills inwards 
    АЙВЭКС Фармасьютикалс с.р.о.     Czech Republic
  • Novo-Passit®
    solution inwards 
    АЙВЭКС Фармасьютикалс с.р.о.     Czech Republic
  • Fistorelax
    pills inwards 
    VALEANT, LLC     Russia
    • Dosage form: & nbspfilm coated tablets
    Composition:
    Composition (per 1 tablet)
    Active components:
    Novo Passito dry extract (obtained from rhizomes and roots of Valeriana officinalis, herbs Melissa officinalis, Hypericum perforatum * grass leaves and flowers of Crataegus monogyna or senticosus, herbs inkarnatnoy Passiflora (passionflower), aggregate fruits hops vulgaris, black elder flowers) 157.5 mg; guaifenesin 200.0 mg
    Excipients:
    Colloidal silica 2.0 mg Microcrystalline cellulose 96.0 mg glycerol 10.0 mg magnesium stearate 10.0 mg lactose monohydrate to 800.0 mg
    Sheath:
    Opadry "AMB 80W31115" green (polyvinyl alcohol 45.52%, Titanium dioxide 26.5%, 20.0% talc, 2.0% soy lecithin, xanthan gum, 0.48%, colorant: 2.5% quinoline yellow, yellow iron oxide 2.0%, dye indigo carmine 1.0%) 24.0 mg.


    Description:

    Tablets are oval, biconvex, covered with a pale green color, with a sharing risk.

    Pharmacotherapeutic group:Sedative agent of plant origin
    ATX: & nbsp

    N.05.C.M   Other sleeping pills and sedatives

    Pharmacodynamics:
    Combined drug, the pharmacological activity of which is due to the constituent components of the extract on it the basis of medicinal plant material with predominantly sedative (calmaction and guaifenesin possessing anxiolytic (anti-anxiety) eeffect.

    Indications:
    • Neurasthenia and neurotic reactions, accompanied by irritability, anxiety, fear, fatigue, absent-mindedness.
    • "Syndrome of the manager" (a condition of a constant mental strain)
    • Insomnia (light forms).
    • Headaches caused by nervous tension.
    • Migraine.
    • Functional diseases of the gastrointestinal tract (dyspeptic syndrome, irritable bowel syndrome).
    • As a symptomatic for neurocirculatory dystonia and menopausal syndrome.
    • Itching dermatoses (eczema atopic and seborrheic, urticaria), caused by psychological stress.

    Contraindications:

    • increased sensitivity to the components of the drug, especially to guaifenesin,
    • myasthenia gravis,
    • children under 12 years.

    Carefully:

    • acute diseases of the gastrointestinal tract,
    • liver disease,
    • epilepsy,
    • alcoholism,
    • diseases or traumas of the brain,

    Pregnancy and lactation:During pregnancy, the drug is prescribed only for absolute indications, if the expected effect for the mother exceeds the possible risk to the fetus. If you need to use the drug during lactation, breastfeeding should be discontinued.
    Dosing and Administration:

    Inside, adults and children over 12 years of age:

    In the absence of other doctor's recommendations, the drug should be taken 1 tablet 3 times daily before meals. After consulting with a doctor, it is possible to increase the dose to 2 tablets 3 times a day. At occurrence of strong weariness or depression it is necessary to reduce morning and daily dose to 1/2 tablets on reception in the morning and in the afternoon, in the evening to accept 1 tablet. The interval between doses should be 4-6 hours.In case of nausea, the drug should be taken with food.

    Side effects:
    Patients usually tolerate the drug well. However, in rare cases, allergic reactions may occur, exanthema, dizziness, fatigue, drowsiness, mild muscle weakness, gastrointestinal disorders, nausea, vomiting, cramps, heartburn, diarrhea, constipation), decreased concentration that quickly pass after drug withdrawal .
    If these or any other side effects occur, you should consult your doctor.

    Overdose:

    Overdose at first is manifested by a feeling of depression and drowsiness. Later, these symptoms can be accompanied by nausea, mild muscle weakness, joint pain, a feeling of heaviness in the stomach. When symptoms of an overdose appear, stop taking the drug. First aid: gastric lavage. Treatment symptomatic. It is necessary to consult a doctor.

    Interaction:
    With the simultaneous administration of Novo-Passit and other drugs, their effect can be enhanced or weakened. Before you start taking the drug simultaneously with other medicines, you should consult your doctor.
    The drug enhances the effect of alcohol and other substances that depress the central nervous system.
    Medicines used to relax skeletal muscles (central muscle relaxation), may increase the risk of side effects of the drug, primarily - muscle weakness.
    St. John's wort extract, contained in the preparation, reduces the effectiveness of hormonal contraception, as well as drugs used primarily after transplantation to reduce the risk of rejection of the transplanted organ or tissue (immunosuppressive drugs), drugs intended for the treatment of AIDS, cardiovascular diseases, bronchial diseases and thromboembolism . Therefore, before starting to take Novo-Passita ® against the background of these drugs, you should consult your doctor.

    Special instructions:
    During treatment with the drug should not drink alcoholic beverages. During the reception of Novo-Passita®, especially for patients with fair skin, exposure to ultraviolet radiation should be avoided (prolonged exposure to direct sunlight, visit to the solarium).
    When taking the drug, do not drive vehicles and mechanisms. If the symptoms do not disappear within 7 days, or if they become worse, and if side effects or other unusual reactions occur, it is recommended that you consult a doctor.

    Form release / dosage:Film coated tablets.
    Packaging:For 30, 60 or 100 tablets in a can of polyethylene with a gasket and a screw cap or 10 tablets in a blister (A1 / PVC). Each bank, 1 or 3 blisters are placed in a cardboard box together with instructions for use.
    Storage conditions:At a temperature of 10 ° to 25 ° C, in a place protected from light. Keep out of the reach of children.
    Shelf life:
    3 years.
    Do not use after the expiration date.

    Terms of leave from pharmacies:Without recipe
    Registration number:П N014519 / 02
    Date of registration:17.03.2008
    The owner of the registration certificate:АЙВЭКС Фармасьютикалс с.р.о.АЙВЭКС Фармасьютикалс с.р.о. Czech Republic
    Manufacturer: & nbsp
    Information update date: & nbsp11.02.2011
    Illustrated instructions
      Instructions
      Up